Microbix Biosystems Inc. (TSX: MBX)

Market Cap	53.56M
Revenue (ttm)	25.39M
Net Income (ttm)	3.52M
Shares Out	135.59M
EPS (ttm)	0.03
PE Ratio	15.34
Forward PE	19.75
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,830
Open	0.395
Previous Close	0.400
Day's Range	0.395 - 0.400
52-Week Range	0.290 - 0.450
Beta	0.34
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 20, 2024

About Microbix Biosystems

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. I...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1988
• Employees: 70
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: MBX